Previous product
Back to products
Balversa (erdafitinib)
CHF40,036.32
Next product
Libtayo (cemiplimab)
CHF8,328.00
Calquence (acalabrutinib)
CHF19,946.55
Calquence (acalabrutinib) is a medication used for the treatment of Mantle Cell Lymphoma (MCL), Chronic Lymphocytic Leukaemia (CLL) and Small Lymphocytic Leukaemia (SLL).
Category: Oncology
Reviews
There are no reviews yet.